A dose-finding and proof-of-concept study of the efficacy and safety of MSP-1014.OX in patients with major depressive disorder

Registration date: Jun 28, 2023
Recruitment status: Recruiting
Funding source: Mindset Pharma (Canada)

~

Neurotoxic effects of hallucinogenic drugs 25H-NBOMe and 25H-NBOH in organotypic hippocampal cultures (Cassiano et al.)

Published: Jun 27, 2023
Heliyon

~

(PREPRINT) Psilocybin decelerates cellular senescence (Hecker et al.)

Available Online: Jun 27, 2023
Research Square

~

Psilocybin: The most effective moral bio-enhancer? (Rakić)

Published: Jun 28, 2023
Bioethics